PMC:7243778 / 2915-3020
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 49 | 47-62 | Disease | denotes | viral infection | MESH:D001102 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T9 | 47-62 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T10 | 53-62 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 47-62 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
| T8 | 81-98 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T9 | 81-98 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T28 | 0-105 | Sentence | denotes | Neutralizing antibodies (nAbs) can inhibit the viral infection via following the viral replication cycle. |